HT
SLDB icon

HAP Trading’s Solid Biosciences SLDB Stock Holding History

HAP Trading’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-673
Closed -$1K – 2039
2022
Q2 		$1K Buy
+673
New +$6.99K ﹤0.01% 1859
2021
Q3 		– Sell
-1,780
Closed -$1K – 2730
2021
Q2 		$1K Sell
1,780
-387
-18% -$25.6K ﹤0.01% 2289
2021
Q1 		$31K Buy
2,167
+967
+81% +$107K ﹤0.01% 1312
2020
Q4 		$55K Buy
+1,200
New +$75.9K ﹤0.01% 1375
2020
Q1 		– Sell
-1,853
Closed -$2K – 1500
2019
Q4 		$2K Buy
+1,853
New +$204K ﹤0.01% 1172

Other funds holding SLDB

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return